Isolation of plasma membranes from bovine corpus luteum possessing adenylate cyclase, 125I-hCG binding and Na---K-ATPase activities by Menon, K. M. J. & Kiburz, J.
Vol. 56, No. 2, 1974 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 
ISOLATION OF PLASMA MEMBRANES FROM BOVINE CORPUS LUTEUM 
POSSESSING ADENYLATE CYCLASE, 1251-hCG BINDING AND 
Na-K-ATPase ACTIVITIES*. 
K.M.J. Menon and J. Kiburz 
Reproductive Endocrinology Program, 
Departments of Obstetrics and Gynecology and 
Biological Chemistry 
The University of Michigan 
Ann Arbor, Michigan 48104 
Received November 15,1973 
SUMMARY 
Plasma membranes from bovine corpora lutea have been puri- 
fied by sucrose density gradient centrifugation. The purified 
membranes, in addition to binding 1251-hCG, also possess hCG- 
stimulated adenylate cyclase and Na-K-ATPase. The relative 
purification of 1251-hCG binding, adenylate cyclase and Na-K- 
ATPase on the basis of the specific activities in the whole 
homogenate were 7.8, 6.4 and 2.6, respectively. The presence 
of both the hormone sensitive adenylate cyclase and 1251-hCG 
binding activities suggest that these plasma membranes might 
possess the 'receptor' for gonadotropin. 
Adenosine 3', 5'-cyclic monophosphate has been shown to 
play an intermediatary role in LH* mediated steroidogenesis in 
the bovine corpus luteum (1). Although LH is also directly cap- 
able of stimulating some of the intracellular events in bovine 
corpus luteum (2), it is believed that one of the primary events 
of LH action is to stimulate the plasma membrane bound adeny- 
late cyclase as has been described with other protein or poly- 
peptide hormones in their respective target tissues (3). In 
this communication, we describe the isolation of plasma membranes 
from bovine corpus luteum which possess 1) hormone stimulated 
*Supported by NIH grants HD 06656 and a Program Project in Re- 
productive Endocrinology from NIH (HD 05315). 
*The following abbreviations are useo: Ml luteinizlng hormone; 
hCG, human chorionic gonadotropin. 
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adenylate cyclase, 2) the ability to bind 125 I-hCG, and 3) sod- 
ium and potassium stimulated ATPase. 
MATERIALS AND METHODS 
Chemicals: Uniformly labeled 14C-ATP, was purchased from New 
England Nuclear Corporation. Phosphoenolypyruvate and pyruvate 
kinase were purchased from Sigma Chemical Co. All other chem- 
icals were conventional commercial products. 
Assay of Adenylate Cyclase: Adenylate cyclase was assayed by 
the procedure of Drummond and Duncan (4). This involves incu- 
bation of l4 C-(U) ATP in the presence of 20 mM phosphoenoly- 
pyruvate, 2 units of pyruvate kinase, 6 mM KCl, 15 mM MgSO4, 
8 mM theophylline, 2 mM cyclic AMP and 40 mM Tris HCl, pH 7.5. 
The final volume of the incubation mixture was 150 Ul. After 
terminating the incubation by boiling for 3 min, the solution 
was centrifuged and 100 ~1 of the supernatant was chromato- 
graphed on paper in 1 M ammonium acetate pH 7.4: Ethanol (3:7) 
system for 16 hr. After drying the chromatogram, the area cor- 
responding to cyclic AMP was cut and radioactivity was deter- 
mined by liquid scintillation counting. 
Isolation of Plasma Membranes: The procedure used for the iso- 
lation of plasma membrane was similar to that described by Marx 
et. al. (5) for the preparation of plasma membrane fraction from 
the rat kidney. Bovine corpora lutea (50 gm) were homogenized 
in 3 vol of Buffer A (0.25 M sucrose, 0.01 M Tris, HCl, pH 7.5 
and 0.001 M EDTA), and filtered through 2 layers of cheese cloth 
to obtain the whole homogenate (WH). The whole homogenate was 
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then diluted with an equal volume of Buffer A and centrifuged 
at 4500 rpm in a Sorvall fitted with an SS 34 rotor. When the 
rotor reached 4500 rpm the motor was turned off. The nuclei 
and unbroken cells were rejected and the above procedure was 
repeated twice more with the supernatant. The resulting super- 
natant was then centri,fuged at 4500 rpm for 15 min when a double 
layered pellet was obtained. The upper portion was resuspended 
in 2 volumes of Buffer A and centrifuged at 4500 rpm for 15 min. 
The resulting pellet was resuspended in 6% of the original vol- 
ume to obtain partially purified membrane (PPM). This fraction 
was then layered on top of 32-42 percent sucrose gradient and 
centrifuged at 23,000 rpm for 90 min using an SW 25-l rotor. 
After the centrifugation, three distinct layers appeared in the 
gradient; a top layer of lipids, a middle layer of plasma mem- 
branes and a bottom layer of a thick pellet. The middle layer 
containing the plasma membranes (PM) was then separated. 
Preparation of 1251-hCG: HCG was iodinated using chloramine-T 
method of Hunter and Greenwood (6) with minor modifications (7). 
Assay of Nat -K+ ATPase: Na+ -K+ -ATPase was assayed by the 
method of Hendler et. al. (8) by measuring the inorganic phos- 
phate released from ATP in the presence of Na+ and Kt minus the 
inorganic phosphate liberated in the absence of these ions. The 
inorganic phosphate released was measured by the prodedure of 
Ames (9). 
RESULTS 
The specific activities of Nat -Kt -ATPase, adenylate CYClaSe 
and the binding of 1251-hCG in the whole homogenate, partially 
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TABLE I 
Summary of the purification of adenylate cyclase 
1251-hCG binding activity and Na+, K+, ATPase 
125 
Na?, Kt 
Treatment Adenylate cyclasea I-hCG bindingb ATPaseC 
whole homogenate 359 units 17, 813 341 units 
Partially puri- 
fied membrane 
764 units 42, 694 517 units 
Purified membrane 2,277 units 139, 621 885 units 
aOne activity unit of adenylate cyclase is 1 picomole of 14C-cyclic AMP 
formed per mg protein per 10 min at 370. The assays were performed in 
the presence of fluoride ion. 
bCPM of 1251-hCG bound per mg protein per 30 min of incubation at 37O 
which can be displaced by the addition of unlabelled hCG. 
%ne unit is defined when the net-difference between the inorganic 
phosphate liberated from ATP in the presence and absence of Na*, Kr and 
Mg2+ is equal to 1 nanomole per 10 min at 370. 
purified membranes and purified membranes are shown in Table 1. 
The specific activities of adenylate cyclase and the binding of 
125 I-hCG were increased 6.4 and 7.8 fold, respectively. The 
+ specific activity of Na -K ' -ATPase was increased 2.6 fold, as 
compared to the specific activity in the whole homogenate. when 
fractions of the sucrose gradient were analyzed for adenylate 
cyclase activity, the enzyme was present in detectable levels 
only in the band corresponding to the plasma membranes (middle 
band). 
125 I-hCG Binding Reaction: The binding of 1251-hCG to whole 
homogenate, partially purified membrane and purified membrane 
preparations are shown in Fig 1. The crossed bars at the bottom 
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Figure 1 The binding of 1251-hCG to whole homogenate (WH), 
partially purified membrane (PPM) and purified 
plasma membrane fractions from bovine corpus 
luteum. The upper portions of the bars with 
parallel lines represent 1251-hCG bound which 
could be competed by unlabelled hCG and the 
bottom portions of the bars with crossed lines 
indicate counts bound irreversibly. The solid 
bars indicate the background radioactivity obtained 
in duplicate determinations. 
indicate non-reversibly bound radioactivity and the top of the 
bar with parallel lines show the binding of 125 I-hCG which was 
'reversed' by the addition of an excess amount of unlabelled 
hCG. The bottom line indicates the non-specific adsorption of 
radioactivity to glass tubes. The experiments were performed 
in duplicates which are represented by the dotted lines. 
The time course of the binding of 1251-hCG to partially 
purified plasma membranes is shown in Fig 2. The binding re- 
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Figure 2 The time course of the binding of 1251-hCG to WH, 
PPM and PM from bovine corpus luteum. One picomole 
of 1251-hCG was added to the reaction mixture in 
control experiment to test the reversibility of the 
reaction. The data represent the binding reaction 
which can be displaced by unlabelled hCG as a func- 
tion of incubation time. 
action was linear at 37O up to 15 min of incubation, after which 
the extent of binding reached a plateau. 
Stimulation of Adenylate Cyclase Activity by hCG: The purified 
membrane fractions also possessed adenylate cyclase activity 
which was stimulated by the addition of 50 ng of unlabelled hCG. 
(Table 2). The incubations were performed in the absence of 
fluoride ion. The data also show that the extent of stimulation 
caused by hCG was higher in the purified membrane fraction as 
compared to the stimulation with whole homogenate and the par- 
tially purified membranes. 
DISCUSSION 
The present study demonstrate the partial purification of 
plasma membranes from the bovine corpus luteum which possess 
the ability to bind 1251-hCG, hormone sensitive adenylate cyclase 
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TABLE II 
In vitro effect of hCG on the adenylate -- 
cyclase activity. 
Preparation hCG added Enzyme activitv 
Whole homogenate 0 55 






50 ng 174 
Purified membrane 0 323 
Purified membrane 50 ng 977 
Enzyme activity is expressed as the picomoles of cyclic AMP formed 
per 30 min per mg of protein. The incubations were performed in 
the absence of fluoride ion. 
and ATPase activity stimulated by Na + and K+ . The latter is 
thought to be involved in the exchange of sodium and potassium 
ions and thus is widely used as a marker for plasma membranes 
(10) - The parallelism between the extent of purification of the 
adenylate cyclase activity and the ability to bind 1251-hCG in 
the purified plasma membranes suggests that these membranes 
possess the 'receptor' for gonadotropin. The present study do 
not, however, rule out the existence of other cellular sites of 
hCG binding in the bovine corpus luteum. 
The binding of 125 I-hCG to plasma membranes were reversed 
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by the addition of unlabelled hCG. The reversibility was obser- 
ved only when the labelled and unlabelled hCG were coincubated 
with the plasma membranes. A fraction of the radioactivity re- 
mained bound to the plasma membranes after the addition of 1 
picomole of hCG suggesting the existence of a non-reversible 
binding component. 
The existence of high affinity gonadotropin binding protein 
has been previously reported in the rat testes (11, 12), ovary 
(13-15) and corpus luteum (16). The presence of gonadotropin 
stimulated adenylate has been reported in the low speed sedi- 
ment of bovine corpus luteum (17). The present experiments 
demonstrate that in addition to gonadotropin binding protein, 
the plasma membranes from bovine corpus luteum also possess 
hormone responsive adenylate cyclase system. Isolation of such 
a receptor would facilitate attempts to understand the nature 
of the relationship between the hormone binding protein and 
the adenylate cyclase - cAMP system. 
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